Mental Health Mobile Apps for Adults
Brief Advice of a List of Mental Health Mobile Apps for Reducing Depressive Symptoms and Anxiety in Adults: a Pilot Randomised Controlled Trial
1 other identifier
interventional
234
1 country
1
Brief Summary
In Hong Kong, the shortage of mental health professionals has been a public health concern for many decades. The World Health Organization (WHO) recommends self-care intervention as one of the most promising and exciting new approaches to improve health and well-being. Rapid development in digital technologies is making population-based self-care interventions possible. The goal of this pilot randomised controlled trial is to provide brief advice of a list of mental health mobile apps for reducing depressive symptoms and anxiety in adults. Participants will be instructed to use four mobile apps for 10 min each day for 30 days. They have freedom to choose which one app to use, or a mix of two or three apps. The Waitlist control group will not receive treatment from the research team during the assessment period. But they will be notified their evaluation results (mild to moderate depression) after they complete the baseline assessment. They will receive the information about mental health hotline services for general public. The hypothesis is that the interventions show preliminary effectiveness in reducing adults' depressive and/or anxiety symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2023
CompletedFirst Submitted
Initial submission to the registry
October 16, 2023
CompletedFirst Posted
Study publicly available on registry
October 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 26, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2024
CompletedApril 1, 2025
March 1, 2025
1.1 years
October 16, 2023
March 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes in depressive symptoms
The Patient Health Questionnaire (PHQ)-9 will be used to measure depressive symptoms. Participants rate the frequency of nine symptoms over the past two weeks on a 4-point Likert scale (from 0=not at all to 3=nearly every day). The total score ranges from 0 to 27, with higher scores indicating a greater severity of depressive symptoms.
T1: baseline; T2: immediate post-intervention (1-month after baseline); T3: 3-month after the intervention
Changes in anxiety symptoms
The Generalized Anxiety Disorder (GAD)-7 will be used to measure anxiety symptoms. Participants rate the frequency of seven symptoms over the past two weeks on a 4-point Likert scale (from 0=not at all to 3=nearly every day). The total score ranges from 0 to 21, with a higher score indicating a higher level of anxiety.
T1: baseline; T2: immediate post-intervention (1-month after baseline); T3: 3-month after the intervention
Secondary Outcomes (3)
Changes in well-being
T1: baseline; T2: immediate post-intervention (1-month after baseline); T3: 3-month after the intervention
Changes in coping self-efficacy (CSE)
T1: baseline; T2: immediate post-intervention (1-month after baseline); T3: 3-month after the intervention
Changes in psychological stress
T1: baseline; T2: immediate post-intervention (1-month after baseline); T3: 3-month after the intervention
Other Outcomes (2)
Utility assessment during application use
T2: immediate post-intervention (1-month after baseline); T3: 3-month after the intervention
The overall satisfaction with the program and subjective changes
After completing all quantitative outcome assessments (3-month after the intervention)
Study Arms (2)
Waitlist control (WC)
NO INTERVENTIONThe WC group will not receive treatment from the research team during the assessment period. But they will be notified their evaluation results (mild to moderate depression) after they complete the baseline assessment. They will receive the information about mental health hotline services for general public (e.g. Social Welfare Department: 2343 2255; Caritas Family Crisis Support Centre: 18288; Joyful Mental Health Foundation: 2301 2303). The intervention group will receive the hotline information as well. If they want to consult a family doctor, information about the primary care provider/directory for mental health care and counselling services will be provided in their preferred district. Their treatment or help-seeking of the formal mental health services will not be intervened. The mobile app list will be provided to the WC group after the assessment period. The instruction session will be delivered to the WC group and provide necessary assistance.
Brief advice of a list of mobile apps
EXPERIMENTALIn the instruction session, the participants will be introduced with the concept of self-care, a list of four mobile apps with high quality and suitability, and the main functions of these apps. Participants will be instructed to use at least one of the apps for 10 min each day for 30 days. They have freedom to choose which one app to use, or a mix of two or three apps. For each app they choose, they will create user accounts by themselves but be reminded to protect privacy. Two reminders will be sent to the participants at the 2nd and 3rd week. The message will include reminders to use the suggested mobile apps, self-care concept, and tips of using the provided apps. If they have not accessed to any of the mobile apps, the project coordinator will discuss the reasons and work together with the participants to overcome the problems.
Interventions
The mobile apps in the list should: (1) focus primarily on anxiety/depression/stress, (2) be available for free download; (3) be available in English or Chinese; and (4) have a user star rating in the app store.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years or above
- Have mild to moderate depression (Patient Health Questionnaire (PHQ) - 9, score 5-14) and/or anxiety (General Anxiety Disorder (GAD) - 7, score 5-14)
- Hong Kong residents who can communicate in Chinese (Cantonese)
- Own a smart phone
You may not qualify if:
- Physically or mentally unable to communicate
- Currently taking antidepressant or anxiolytic medication or receiving active psychotherapy in the past 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hong Kong Metropolitan University
Hong Kong, 000000, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yuying Sun, PhD
Hong Kong Metropolitan University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 16, 2023
First Posted
October 25, 2023
Study Start
August 1, 2023
Primary Completion
August 26, 2024
Study Completion
October 31, 2024
Last Updated
April 1, 2025
Record last verified: 2025-03